Unsurprisingly, the pharmacological targeting of CoREST in human cancer has become a subject of intense investigation, whereby strategies have been developed to target both individual members of the complex, or multiple cofactors simultaneously, in an attempt to recover tumour suppressor expression (25,26). The gene discussed is RCOR1; the disease is neoplasm.